Nanda Kishore Routhu

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata S. Bollimpelli et al. · Nature Communications · 2021 · 97 citations · Full text

Lung Inflammation, Immune Pathology, Immunology +16

A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Nanda Kishore Routhu, Narayanaiah Cheedarla, Sailaja Gangadhara et al. · Immunity · 2021 · 90 citations · Full text

Vaccination, Vaccine Development, Immune Pathology +6

Glycosylation of Zika Virus is Important in Host–Virus Interaction and Pathogenic Potential

Nanda Kishore Routhu, Sylvain Lehoux, Emily A. Rouse et al. · International Journal of Molecular Sciences · 2019 · 50 citations · Full text

Microbial Pathogens, Viral Pathogenesis, Glycobiology +16

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai et al. · Science Immunology · 2022 · 47 citations · Full text

Nucleocapsid Protects, Immunology, Mva/sdfcs Vaccine +16

Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates

Nanda Kishore Routhu, Samuel D. Stampfer, Lilin Lai et al. · Science Immunology · 2023 · 28 citations · Full text

Vaccination, Vaccine Development, Sars-cov-2 Ba.5 Infection +11